71370988
reacted to
$Aptevo Therapeutics (APVO.US)$
Aptevo Highlights the Potential of the Company's Robust Portfolio in Cancer Immunotherapy, the Success of Bispecifics as a Category, and Their Growing Importance in the Oncology Treatment Paradigm
Aptevo Therapeutics (NASDAQ:APVO)provided updates on its oncology pipeline focusing on bispecific antibodies for cancer treatment. The company highlighted two clinical programs: mipletamig for AML, which showed 90% reduction in leukemic blasts in its first Phase 1b/2 ...
Aptevo Highlights the Potential of the Company's Robust Portfolio in Cancer Immunotherapy, the Success of Bispecifics as a Category, and Their Growing Importance in the Oncology Treatment Paradigm
Aptevo Therapeutics (NASDAQ:APVO)provided updates on its oncology pipeline focusing on bispecific antibodies for cancer treatment. The company highlighted two clinical programs: mipletamig for AML, which showed 90% reduction in leukemic blasts in its first Phase 1b/2 ...
2
71370988
commented on
$CERo Therapeutics (CERO.US)$ what a fuckn piece of trash
1
14
71370988
commented on
$Elevai Labs (ELAB.US)$ they want your shares lol. the company wants control. they can have my shares .30-50 cents. tiny float could run to $1
5
4
$TC BioPharm (TCBP.US)$ why it keeps falling hardly, started from yesterday, I bougha bunch at 1.07 and it was doing good for a day, but suddenly it started sinking!!!! any clue???
1
3
71370988
liked
$Tempest Therapeutics (TPST.US)$
13/11/2024 - 05:21
Building upon a successful end-of-Phase 2 meeting, received FDA “Study May Proceed” letter for pivotal Phase 3 trial of amezalpat (TPST-1120) combination therapy to treat first-line HCC
Announced agreement with Roche to support advancement of amezalpat into first-line HCC pivotal Phase 3 trial
Received final funding approval from NCI to move TPST-1495 into a Phas...
13/11/2024 - 05:21
Building upon a successful end-of-Phase 2 meeting, received FDA “Study May Proceed” letter for pivotal Phase 3 trial of amezalpat (TPST-1120) combination therapy to treat first-line HCC
Announced agreement with Roche to support advancement of amezalpat into first-line HCC pivotal Phase 3 trial
Received final funding approval from NCI to move TPST-1495 into a Phas...
2
1
71370988
commented on